MedTrace Logo

A Randomized Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.

NCT00157833 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2006-06-26

No results posted yet for this study

Summary

This open randomized, parallel group, 6 week trial in two rural outpatient clinics will compare the safety and efficacy of a six dose coartemether regimen with 3 dose artekin regimen for the treatment of acute, uncomplicated falciparum and vivax malaria in adults and children (\>10kg).

Conditions

  • Falciparum Malaria
  • Vivax Malaria

Interventions

DRUG

Artekin / Coartemther

Sponsors & Collaborators

  • National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

    collaborator OTHER

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • Wellcome Trust

    collaborator OTHER

  • Menzies School of Health Research

    lead OTHER

Principal Investigators

  • Ric N Price · Menzies School of Health Research

  • Emiliana Tjitra · National Institute of Health Research and Development

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Completion
2005-08-31

Countries

  • Indonesia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00157833 on ClinicalTrials.gov